This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Characteristics of Benign and Malignant Lesions on CEM

Characteristics of Benign and Malignant Lesions on CEM

Format

Slide Lecture Series

Time to Complete

1 hour

Released

December 2, 2015

Expires

January 20, 2018
Add to Queue


Important

The expiration date for this activity has been extended and the activity was re-released on January 19, 2017.

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider




Provided by EXCEL Continuing Education

Commercial Supporter

Supported by GE Healthcare

Program Description

Accurate mammograms are limited in dense breasts where surrounding fibroglandular tissue decreases the view of lesions. Even when tumors are detected, the full extent of the disease may not be clearly visible. New advances in breast imaging technologies include the use of contrast-enhanced spectral mammography, a safe and effective screening tool for the potential detection and diagnosis of cancerous lesions. This is part 3 in a series of 5 independent 1 hour accredited activities that will discuss the use of this screening tool in clinical practice as it compares to other imaging technologies.

Intended Audience

Radiologists, breast imaging specialists, radiation oncologists, surgical oncologists, breast cancer oncologists, fellows, residents, and other healthcare professionals who care for patients with breast cancer.

Educational Objectives

At the conclusion of this activity, participants should be able to:

  • Identify CEM characteristics for infiltrating lobular (ILC), infiltrating ductal carcinoma (IDC), and DCIS
  • Recognize clumped enhancement and nodular regional enhancement of DCIS
  • Diagnose benign lesions including cysts and fibroadenomas through CEM
  • Review logistics when assessing benign and malignant lesions on CEM

Conflict Of Interest Disclosure Policy

EXCEL Continuing Education requires all those who are in a position to control the content of this activity including faculty, planners, peer reviewers, and EXCEL staff to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to EXCEL policy.

The existence or absence of COI for anyone in a position to control content is disclosed below:

Dr. Geetika Klevos, MD, peer reviewer, has no relevant financial information to disclose.
EXCEL staff have no relevant financial information to disclose.

Faculty

Lydia Liao, MD, PhD, MPH
Director of Cooper Breast Imaging Centers
MD Anderson-Cooper Cancer Institute
Professor of Radiology
Cooper Medical School of Rowan University
Camden, NJ

Dr. Lydia Liao, MD, presenter, has indicated that she has received honoaria as a speaker for GE Healthcare and Devicor Medical.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

EXCEL Continuing Education is accredited by the Accrediation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

EXCEL Continuing Education designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. European physicians can earn their EACCMEC®s by completing e-learning programs from accredited providers from the United States that have been certified for AMA PRA Category 1 CreditTM. For more information, go to http://www.uems.eu/uems-activities/accreditation/eaccme.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For questions regarding this activity, please contact EXCEL Continuing Education at info@excelcme.com or phone (305) 630-9414.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue